Home › Asset managers › Compare 2024-2025 › Vanguard vs Northern Trust
Vanguard 2024-2025 · Northern Trust 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 94,997 | 86,137 | 5,768 | 3,092 | 93.7% | 92.7% |
| Board proposals | 74,087 | 66,390 | 5,096 | 2,601 | 92.9% | 91.8% |
| E&S shareholder proposals | 258 | 94 | 37 | 127 | 71.8% | 60.7% |
| Other items | 20,652 | 19,653 | 635 | 364 | 96.9% | 96.2% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
7,697 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Vanguard | Northern Trust |
|---|---|---|---|---|---|---|
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Authorization of the Board and Its Authorized Persons to Handle All Related Matters Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Completeness and Compliance of Implementation of Legal Proceedings of the Transaction and Validity of the Submitted Legal Documents Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Confidentiality Measures and Confidentiality System Adopted for This Transaction Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Description of the Basis and Fairness and Reasonableness of the Pricing of the Transaction Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Distribution Arrangement of Undistributed Earnings Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Fluctuation of the Company's Stock Price Before the Release of Information on This Transaction Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Impact of Dilution of Current Returns on Major Financial Indicators, the Relevant Measures to be Taken and Commitment from Relevant Parties Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Independence of Appraiser, the Validity of Hypothesis, the Relevance of Valuation Method and Purpose and Approach as Well as the Fairness of Pricing Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Amount Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Amount and Number of Issues Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Manner and Target Subscribers Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Type, Par Value and Listing Location Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Lock-Up Period Arrangement Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Overall Plan Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Performance Commitment and Compensation Arrangement Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Pricing Reference Date and Issue Price Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Purchases and Sales of Assets in the Twelve Months Prior to the Transaction Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Report (Draft) and Summary on Issuance of Shares and Acquisition by Cash as Well as Raising Supporting Funds and Related Party Transactions Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Report on the Usage of Previously Raised Funds Capital Structure |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Resolution Validity Period Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Signing of Conditional Agreement to the Issuance of Shares and Acquisition by Cash as well as Performance Compensation Agreement Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Target Assets Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies With Article 18 and 21 of the Measures for the Continuous Supervision of ChiNext Listed Companies (Trial) and Article 8 of the Shenzhen Stock Exchange Listed Company Major Asset Restructuring Review Rules Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies With Article 4 of Guidelines for the Supervision of Listed Companies No. 9 - Regulatory Requirements for Listed Companies to Plan and Implement Major Asset Restructuring Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies with Articles 11 and 43 of the Measures for the Administration of Major Asset Restructuring of Listed Companies Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies with the Relevant Provisions of the Administrative Measures for the Registration of Securities Issuance of Listed Companies Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Constitute as Major Asset Restructuring and Does Not Constitute as Restructuring and Listing Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Parties Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Price and Payment Method Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Use of Proceeds Capital Structure |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve the Company's Plan for Issuance of Shares and Acquisition by Cash as Well as Raising Supporting Funds Complies with Relevant Laws and Regulations Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve the Relevant Entity of Transaction Does Not Exist in Article 12 of Listed Company Supervision Guidelines No. 7 and Article 30 of the Guidelines for Self-regulatory Supervision No. 8 (Revised in 2023) Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | April 15, 2025 | Approve Use of Idle Raised Funds and Own Funds for Cash Management Extraordinary Transactions |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| CSPC PHARMACEUTICAL GROUP LTD. | May 30, 2025 | Elect Wang Bo as Director Director Elections |
Board | For | FOR 6 funds |
AGAINST 3 funds |
| CSW INDUST | August 15, 2024 | Election of Directors: Michael Gambrell Director Elections |
Board | Not determined | FOR 15 funds |
WITHHOLD 3 funds |
| CTBC FINANCIAL HOLDING CO. LTD. | June 13, 2025 | Approve Issuance of Restricted Stocks Compensation |
Board | For | FOR 6 funds |
AGAINST 2 funds |
| CTBC FINANCIAL HOLDING CO. LTD. | June 13, 2025 | Elect SHENG-YUNG YANG, with Shareholder No. 1018764, as Independent Director Director Elections |
Board | For | FOR 6 funds |
AGAINST 2 funds |
| CTOS DIGITAL BHD | June 25, 2025 | Elect Loh Kok Leong as Director Director Elections |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| CTP N.V. | April 22, 2025 | AUTHORIZE BOARD TO EXCLUDE PREEMPTIVE RIGHTS FROM SHARE ISSUANCES Capital Structure |
Board | For | FOR 8 funds |
AGAINST 3 funds |
| CTP N.V. | April 22, 2025 | GRANT BOARD AUTHORITY TO ISSUE SHARES UP TO 10 PERCENT OF ISSUED CAPITAL FOR GENERAL PURPOSES AND ADDITIONAL 10 PERCENT OF ISSUED CAPITAL IN CASE OF MERGERS, ACQUISITIONS, OR STRATEGIC ALLIANCES Capital Structure |
Board | For | FOR 8 funds |
AGAINST 3 funds |
| CTS EVENTIM AG & CO. KGAA | May 21, 2025 | Approve Remuneration Policy Compensation |
Board | For | FOR 5 funds |
AGAINST 4 funds |
| CUSTODIAN PROPERTY INCOME REIT PLC | August 8, 2024 | RE-ELECT IAN MATTIOLI AS DIRECTOR Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CUSTOM TRU | June 12, 2025 | To elect each of the four Class C directors to serve until the 2028 annual meeting of stockholders and until his or her successor is duly elected and qualified: Fred Ross Director Elections |
Board | Not determined | WITHHOLD 9 funds |
FOR 1 fund |
| CUTERA INC. | July 15, 2024 | Approval of the amendment and restatement of our 2019 Equity Incentive Plan to increase the total shares available for issuance under the 2019 Equity Incentive Plan by 2,395,275 shares. Compensation |
Board | For | FOR 9 funds |
AGAINST 2 funds |
| CUTERA INC. | July 15, 2024 | Election of Directors: Jeryl Hilleman Director Elections |
Board | For | FOR 9 funds |
AGAINST 2 funds |
| CUTERA INC. | July 15, 2024 | Election of Directors: Keith Sullivan Director Elections |
Board | For | FOR 9 funds |
AGAINST 2 funds |
| CUTERA INC. | July 15, 2024 | Election of Directors: Kevin Cameron Director Elections |
Board | For | FOR 9 funds |
AGAINST 2 funds |
| CVC CAPITAL PARTNERS PLC | May 20, 2025 | Elect Rolly van Rappard as Director Director Elections |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| CYBERAGENT INC. | December 13, 2024 | Elect Director Fujita, Susumu Director Elections |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| CYBERPOWER SYSTEMS INC. | May 28, 2025 | Approve Issuance of Restricted Stocks Compensation |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| CYIENT LTD. | July 1, 2024 | Reelect Muthiah Murugappan Murugappan as Director Director Elections |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| D'IETEREN GROUP | December 6, 2024 | Approve Dividends Capital Structure |
Board | For | FOR 6 funds |
AGAINST 3 funds |
| D/S NORDEN A/S | March 12, 2025 | Amend Remuneration Policy Compensation |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| D/S NORDEN A/S | March 12, 2025 | Approve Creation of DKK 4 Million Pool of Capital with Preemptive Rights; Approve Creation of DKK 4 Million Pool of Capital without Preemptive Rights; Maximum Increase in Share Capital under Both Authorizations up to DKK 4 Million Capital Structure |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| D/S NORDEN A/S | March 12, 2025 | Approve Remuneration Report (Advisory Vote) Compensation |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| D/S NORDEN A/S | March 12, 2025 | Authorize Share Repurchase Program Capital Structure |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| D/S NORDEN A/S | March 12, 2025 | Reelect Johanne C F Riegels as Director Director Elections |
Board | For | FOR 6 funds |
ABSTAIN 1 fund |
| D/S NORDEN A/S | March 12, 2025 | Reelect Klaus Nyborg as Director Director Elections |
Board | For | FOR 6 funds |
ABSTAIN 1 fund |
| D/S NORDEN A/S | March 21, 2025 | Approve Creation of DKK 4 Million Pool of Capital with Preemptive Rights; Approve Creation of DKK 4 Million Pool of Capital without Preemptive Rights; Maximum Increase in Share Capital under Both Authorizations up to DKK 4 Million Capital Structure |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| DAH SING BANKING GROUP LTD. | May 30, 2025 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights Capital Structure |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| DAH SING BANKING GROUP LTD. | May 30, 2025 | Elect Robert Tsai-To Sze as Director Director Elections |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| DAICEL CORP. | June 20, 2025 | Elect Director Ogawa, Yoshimi Director Elections |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| DAICEL CORP. | June 20, 2025 | Elect Director Sakaki, Yasuhiro Director Elections |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| DAIDO STEEL CO. LTD. | June 25, 2025 | Elect Director Ishiguro, Takeshi Director Elections |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| DAIDO STEEL CO. LTD. | June 25, 2025 | Elect Director and Audit Committee Member Niwa, Tetsuya Director Elections |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| DAIEI KANKYO CO. LTD. | June 26, 2025 | Elect Director Kaneko, Fumio Director Elections |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| DAIHEN CORP. | June 26, 2025 | Appoint Statutory Auditor Morimoto, Keiki Compensation |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| DAIHEN CORP. | June 26, 2025 | Elect Director Minomo, Shoichiro Director Elections |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| DAIHEN CORP. | June 26, 2025 | Elect Director Tajiri, Tetsuya Director Elections |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| DAILY JOURNAL CORP. | February 19, 2025 | Election of four Directors: John B. Frank Director Elections |
Board | For | FOR 10 funds |
AGAINST 2 funds |
| DAILY JOURNAL CORP. | February 19, 2025 | Election of four Directors: Mary Conlin Director Elections |
Board | For | FOR 10 funds |
AGAINST 2 funds |
| DAIO PAPER CORP. | June 26, 2025 | Elect Director Wakabayashi, Yorifusa Director Elections |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| DAISEKI CO. LTD. | May 22, 2025 | Elect Director Yamamoto, Tetsuya Director Elections |
Board | For | FOR 6 funds |
AGAINST 2 funds |
| DAISHI HOKUETSU FINANCIAL GROUP INC. | June 25, 2025 | Elect Director Namiki, Fujio Director Elections |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| DAISHI HOKUETSU FINANCIAL GROUP INC. | June 25, 2025 | Elect Director Ueguri, Michiro Director Elections |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| DAISHIN SECURITIES CO. LTD. | March 21, 2025 | Elect Cho Seon-young as Outside Director Director Elections |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| DAISHIN SECURITIES CO. LTD. | March 21, 2025 | Elect Cho Seon-young as a Member of Audit Committee Director Elections |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| DAISHIN SECURITIES CO. LTD. | March 21, 2025 | Elect Han Seung-hui as Outside Director Director Elections |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| DAISHIN SECURITIES CO. LTD. | March 21, 2025 | Elect Kim Chang-su as Outside Director Director Elections |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| DAISHIN SECURITIES CO. LTD. | March 21, 2025 | Elect Kim Chang-su as a Member of Audit Committee Director Elections |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| DAISHIN SECURITIES CO. LTD. | March 21, 2025 | Elect Kim Seong-ho as Outside Director Director Elections |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| DAISHIN SECURITIES CO. LTD. | March 21, 2025 | Elect Song Hyeok as Inside Director Director Elections |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| DAISHIN SECURITIES CO. LTD. | March 21, 2025 | Elect Won Yoon-hui as Outside Director to Serve as an Audit Committee Member Director Elections |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| DAIWA HOUSE INDUSTRY CO. LTD. | June 27, 2025 | Appoint Statutory Auditor Oyaide, Ryuichi Compensation |
Board | For | AGAINST 8 funds |
FOR 9 funds |
| DAIWA HOUSE INDUSTRY CO. LTD. | June 27, 2025 | Appoint Statutory Auditor Takashige, Yoshihiro Compensation |
Board | For | AGAINST 8 funds |
FOR 9 funds |
| DAKOTA GOLD CORP. | May 13, 2025 | Election of Directors: Alice Schroeder Director Elections |
Board | For | WITHHOLD 8 funds |
FOR 1 fund |
| DAKOTA GOLD CORP. | May 13, 2025 | Election of Directors: Amy K. Koenig Director Elections |
Board | For | WITHHOLD 8 funds |
FOR 1 fund |
| DAKOTA GOLD CORP. | May 13, 2025 | Election of Directors: Gerald Aberle Director Elections |
Board | For | WITHHOLD 8 funds |
FOR 1 fund |
| DAKOTA GOLD CORP. | May 13, 2025 | Election of Directors: Jennifer S. Grafton Director Elections |
Board | For | WITHHOLD 8 funds |
FOR 1 fund |
| DAKOTA GOLD CORP. | May 13, 2025 | Election of Directors: Robert Quartermain Director Elections |
Board | For | WITHHOLD 8 funds |
FOR 1 fund |
| DAKOTA GOLD CORP. | May 13, 2025 | Election of Directors: Stephen O'Rourke Director Elections |
Board | For | WITHHOLD 8 funds |
FOR 1 fund |
| DALMIA BHARAT LTD. | June 30, 2025 | Reelect Yadu Hari Dalmia as Director Director Elections |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| DANIELI & C. OFFICINE MECCANICHE SPA | October 25, 2024 | Approve Remuneration Policy Compensation |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| DANIELI & C. OFFICINE MECCANICHE SPA | October 25, 2024 | Approve Second Section of the Remuneration Report Compensation |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| DANIELI & C. OFFICINE MECCANICHE SPA | October 25, 2024 | Authorize Share Repurchase Program and Reissuance of Repurchased Shares Capital Structure |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| DANIMER SCIENTIFIC INC. | July 9, 2024 | Election of Directors: John P. Amboian Director Elections |
Board | For | FOR 8 funds |
WITHHOLD 1 fund |
| DANSKE BANK A/S | March 20, 2025 | Reelect Martin Norkjaer Larsen as Director Director Elections |
Board | For | FOR 7 funds |
ABSTAIN 5 funds |
| DAQIN RAILWAY CO. LTD. | May 21, 2025 | Approve to Authorize the Board of Directors to Decide on the Company's Interim Profit Distribution Capital Structure |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| DASSAULT AVIATION SA | May 16, 2025 | Authorize Repurchase of Up to 10 Percent of Issued Share Capital Capital Structure |
Board | For | FOR 5 funds |
AGAINST 3 funds |
| DATANG INTERNATIONAL POWER GENERATION CO. LTD. | June 27, 2025 | Elect Jiang Jianhua as Director Director Elections |
Board | For | FOR 5 funds |
AGAINST 2 funds |
← Previous Page 13 of 77 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built November 1, 2026 from SEC Form N-PX filings.